NOV. 13 11:42 A.M. ET Bodisen Biotech Inc., a China-based fertilizer maker, said late Sunday it received a letter from the American Stock Exchange warning that it is out of compliance with certain listing standards.
The exchange said it believes Bodisen made insufficient or inaccurate disclosure in public filings on its relationship with, and payments to, New York Global Group and its affiliates both prior to and subsequent to its listing on the exchange.
The Amex also expressed concern that Bodisen has internal control issues related to its accounting and financial reporting obligations in the context of its relationship with the company.
